In our study, CAD patients with high apoA-I levels showed a clear trend towards decreased all-cause and CVD mortality.
← all excerpts
Serum lipids, apolipoproteins, and mortality among coronary artery disease patients.
1
—
—
In our study, CAD patients with high apoA-I levels showed a clear trend towards decreased all-cause and CVD mortality.